-
EP3341372
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3341372
| EP3341372 - TGF BETA RECEPTOR ANTAGONISTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.01.2020 Database last updated on 12.07.2024 | |
| Former | Examination is in progress Status updated on 22.02.2019 | ||
| Former | Request for examination was made Status updated on 01.06.2018 | ||
| Former | The international publication has been made Status updated on 04.03.2017 | Most recent event Tooltip | 10.01.2020 | Application deemed to be withdrawn | published on 12.02.2020 [2020/07] | Applicant(s) | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543 / US | [2018/27] | Inventor(s) | 01 /
BORZILLERI, Robert M. c/o Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, New Jersey 08543 / US | 02 /
FINK, Brian E. c/o Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, New Jersey 08543 / US | 03 /
HARIKRISHNAN, Lalgudi S. c/o Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, New Jersey 08543 / US | 04 /
VELAPARTHI, Upender c/o Bristol-Myers Squibb Company 5 Research Parkway Wallingford, Connecticut 06492 / US | 05 /
BALIGAR, Vishweshwaraiah c/o Syngene International Limited Biocon Special Economic Zone Biocon Park Plot No. 2&3 Bommasandra Industrial Area IV Phase, Jigani Link Road, Bommasandra Karnataka Bangalore 560 099 / IN | 06 /
RAHAMAN, Hasibur c/o Syngene International Limited Biocon Special Economic Zone Biocon Park Plot No. 2&3 Bommasandra Industrial Area IV Phase, Jigani Link Road, Bommasandra Karnataka Bangalore 560 099 / IN | 07 /
WARRIER, Jayakumar Sankara c/o Syngene International Limited Biocon Special Economic Zone Biocon Park Plot No. 2&3 Bommasandra Industrial Area IV Phase, Jigani Link Road, Bommasandra Karnataka Bangalore 560 099 / IN | [2018/27] | Representative(s) | Kling, Edouard Swords Laboratories, Ireland Swiss Branch, Steinhausen Hinterbergstrasse 16 6312 Steinhausen / CH | [2018/27] | Application number, filing date | 16759926.5 | 23.08.2016 | [2018/27] | WO2016US48136 | Priority number, date | US201562209531P | 25.08.2015 Original published format: US 201562209531 P | [2018/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017035118 | Date: | 02.03.2017 | Language: | EN | [2017/09] | Type: | A1 Application with search report | No.: | EP3341372 | Date: | 04.07.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.03.2017 takes the place of the publication of the European patent application. | [2018/27] | Search report(s) | International search report - published on: | EP | 02.03.2017 | Classification | IPC: | C07D473/34, A61K31/52, A61P35/00 | [2018/27] | CPC: |
A61K31/52 (EP,KR,US);
C07D473/34 (EP,KR,US);
A61K45/06 (KR);
A61P35/00 (KR);
A61P35/02 (EP,US);
A61K2121/00 (US);
A61K2300/00 (KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/27] | Title | German: | TGF-BETA-REZEPTOR-ANTAGONISTEN | [2018/27] | English: | TGF BETA RECEPTOR ANTAGONISTS | [2018/27] | French: | ANTAGONISTES DU RÉCEPTEUR TGF BÊTA | [2018/27] | Entry into regional phase | 15.02.2018 | National basic fee paid | 15.02.2018 | Designation fee(s) paid | 15.02.2018 | Examination fee paid | Examination procedure | 15.02.2018 | Examination requested [2018/27] | 15.02.2018 | Date on which the examining division has become responsible | 30.08.2018 | Amendment by applicant (claims and/or description) | 26.02.2019 | Despatch of a communication from the examining division (Time limit: M06) | 10.09.2019 | Application deemed to be withdrawn, date of legal effect [2020/07] | 04.10.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/07] | Fees paid | Renewal fee | 10.08.2018 | Renewal fee patent year 03 | 15.08.2019 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]US2005004143 (DUGAR SUNDEEP [US], et al) [X] 1,2,6-13 * claims 1, 6, 8, 9, 19 * * page 3; compound 1 *[I] 3-5 | by applicant | WO2006029879 | WO2006105021 | WO2006122150 | WO2007005874 | WO2007075598 | WO2008036653 | WO2008036642 | WO2008132601 | WO2009009116 | WO2009044273 | WO2009073620 | WO2009115665 | WO2010019570 | WO2010077634 | WO2011028683 | WO2011056652 | WO2011070024 | WO2011107553 | WO2011109400 | WO2011131407 | WO2011140249 | WO2012032433 | WO2012142237 | WO2012145493 | WO2013079174 | WO2013087699 | WO2013119716 | WO2013132044 | WO2013169264 | WO2014008218 | WO2014036357 | - LING; LEE, CURRENT PHARMACEUTICAL BIOTECH., (2011), vol. 12, pages 2190 - 2202 | - SHI; MASSAGUE, CELL, (2003), vol. 113, pages 685 - 700 | - WEISS; ATTISANO, WIRES DEVELOPMENTAL BIOLOGY, (2013), vol. 2, pages 47 - 63 | - BEMABEU ET AL., BIOCHEM BIOPHYS ACTA, (2009), vol. 1792, pages 954 - 73 | - HARRADINE ET AL., ANNALS OF MEDICINE, (2006), vol. 38, pages 403 - 14 | - BUIJS ET AL., CURR PHARMACEUTICAL BIOTECH, (2011), vol. 12, pages 2121 - 37 | - The Peptides: Analysis, Synthesis, Biology, ACADEMIC PRESS, (1981), vol. 3 | - WIDDER, K. ET AL., Methods in Enzymology, ACADEMIC PRESS, (1985), vol. 112, pages 309 - 396 | - BUNDGAARD, H. ET AL., "Design and Application of Prodrugs (chapter 5)", BUNDGAARD, H. ET AL., KROSGAARD-LARSEN, P. ET AL., A Textbook of Drug Design and Development, HARWOOD ACADEMIC PUBLISHERS, (1991), pages 113 - 191 | - BUNDGAARD, H., ADV. DRUG DELIV. REV., (1992), vol. 8, pages 1 - 38 | - BUNDGAARD, H. ET AL., J. PHARM. SCI., (1988), vol. 77, page 285 | - KAKEYA, N. ET AL., CHEM. PHARM. BULL., (1984), vol. 32, page 692 | - RAUTIO, J, Prodrugs and Targeted Delivery (Methods and Principles in Medicinal Chemistry), WILEY-VCH, (2011), vol. 47 |